BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2002

View Archived Issues

Inhale Therapeutic Systems extends research collaboration with Johnson & Johnson

Read More

PK-11195 may be effective in improving clinical outcomes in acute myeloid leukemia

Read More

In vivo protection against ischemia-induced apoptosis in the brain by KR-31378

Read More

A new class of PDE4 inhibitors shows potential for the treatment of inflammatory lung diseases

Read More

Improvement of learning impairment obtained with Otsuka's sigma/5-HT1A receptor agonist

Read More

Efficacy of long-term DPP-IV inhibition in the treatment of diabetes confirmed in rat studies

Read More

Anecortave stabilizes or improves vision in AMD according to preliminary phase II results

Read More

Long-acting prophylactic efficacy demonstrated for ISV-401 in rabbit keratitis model

Read More

VEGF antagonist distinguishes between pathological and appropriate retinal revascularization

Read More

Tick-derived histamine-binding protein effective in murine model of allergic conjunctivitis

Read More

Complete pain relief obtained in hemicrania continua patients with high-dose COX-2 inhibitors

Read More

Donepezil improves cognition in patients with vascular dementia

Read More

Ribozyme reveals clinical program progress

Read More

First-quarter 2002 highlights offered by Icos

Read More

IL-13-PE38 granted fast track designation for malignant glioma

Read More

New Telik compounds have the ability to enhance insulin-dependent glucose uptake

Read More

ISTA acquires rights to late-stage ophthalmology products

Read More

Immtech and Neurochem enter agreement for antiamyloid compounds

Read More

1-Arylpiperazines claimed by Merck KGaA for use in schizophrenia

Read More

Merck Frosst synthesizes dipeptide inhibitors of caspase 3

Read More

BioVisioN and Novo Nordisk evaluate new therapeutic approaches to type 2 diabetes

Read More

Antitumor activity reported by SRI for benzopyran-based enzyme inhibitors

Read More

Merck presents newest inhibitors of farnesyl- and geranylgeranyltransferases

Read More

Potent and selective mu opioid agonists with analgesic activity

Read More

Farnesoid X receptor modulators identified at Tularik

Read More

Protonix delayed-release tablets approved for long-term treatment of Zollinger-Ellison syndrome

Read More

Bioption and IAVI partner on AIDS vaccines

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • Cross section illustration of HIV virus parts

    Anticancer drug exerts potent HIV antiviral effects

    BioWorld Science
    A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing